BACKGROUND. Preterm delivery is the leading cause of neonatal mortality in the United States, but efforts to address the problem are hampered by the inability to predict accurately which pregnancies are at risk. We postulated that damage to the fetal membranes may release fetal fibronectin into the cervix and vagina, giving rise to a biochemical marker for preterm delivery. METHODS. We measured fetal-fibronectin concentrations in cervical and vaginal secretions, amniotic fluid, and maternal plasma with a sensitive immunoassay using the monoclonal antibody FDC-6. Immunohistochemical studies were used to determine the distribution of fetal fibronectin in the placenta and amniochorionic membranes and to ascertain its cell of origin. RESULTS. Women with uncomplicated pregnancies (n = 163) who delivered at term rarely had cervicovaginal fetal-fibronectin concentrations above 0.05 micrograms per milliliter between 21 and 37 weeks of gestation (11 of 267 cervical samples [4 percent] and 9 of 267 vaginal samples [3 percent]. High levels of fetal fibronectin were detected in amniotic fluid and in the cervical or vaginal secretions of 93.8 percent of the women with preterm rupture of membranes (n = 65). Cervical or vaginal fetal fibronectin was also present in 50.4 percent of the women with preterm uterine contractions and intact membranes (n = 117), and its presence identified the women who delivered before term (n = 60) with a sensitivity of 81.7 percent and a specificity of 82.5 percent. In the placenta and membranes, fetal fibronectin was found at points of contact with the uterine wall. CONCLUSIONS. The presence of cervicovaginal fetal fibronectin in the second and third trimesters of pregnancy identifies a subgroup of women who are at high risk for preterm delivery. This phenomenon may reflect the separation of the chorion from the decidual layer of the uterus, with the release of intact or degraded chorionic components of the extracellular matrix into the cervical and vaginal secretions.
Source Information
Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai School of Medicine, New York, NY 10029-6574.
This article has been cited by other articles:
Turan, O. M., Turan, S., Funai, E. F., Buhimschi, I. A., Copel, J. A., Buhimschi, C. S.
(2007). Fetal Adrenal Gland Volume: A Novel Method to Identify Women at Risk for Impending Preterm Birth. Obstet Gynecol
109: 855-862
[Abstract][Full Text]
Lee, S. E., Park, J. S., Norwitz, E. R., Kim, K. W., Park, H. S., Jun, J. K.
(2007). Measurement of Placental Alpha-Microglobulin-1 in Cervicovaginal Discharge to Diagnose Rupture of Membranes. Obstet Gynecol
109: 634-640
[Abstract][Full Text]
Goldenberg, R. L., Andrews, W. W., Hoffman, I., Fawzi, W., Valentine, M., Young, A., Read, J. S., Brown, E. R., Mudenda, V., Kafulafula, G., Mwinga, K., Taha, T. E.
(2007). Fetal Fibronectin and Adverse Infant Outcomes in a Predominantly Human Immunodeficiency Virus-Infected African Population: A Randomized Controlled Trial. Obstet Gynecol
109: 392-401
[Abstract][Full Text]
Sciscione, A., Hoffman, M. K., DeLuca, S., O'Shea, A., Benson, J., Pollock, M., Vakili, B.
(2005). Fetal Fibronectin as a Predictor of Vaginal Birth in Nulliparas Undergoing Preinduction Cervical Ripening. Obstet Gynecol
106: 980-985
[Abstract][Full Text]
Shankar, R., Gude, N., Cullinane, F., Brennecke, S., Purcell, A. W, Moses, E. K
(2005). An emerging role for comprehensive proteome analysis in human pregnancy research. Reproduction
129: 685-696
[Abstract][Full Text]
Tekesin, I., Marek, S., Hellmeyer, L., Reitz, D., Schmidt, S.
(2005). Assessment of Rapid Fetal Fibronectin in Predicting Preterm Delivery. Obstet Gynecol
105: 280-284
[Abstract][Full Text]
Roman, A. S., Koklanaris, N., Paidas, M. J., Mulholland, J., Levitz, M., Rebarber, A.
(2005). "Blind" Vaginal Fetal Fibronectin as a Predictor of Spontaneous Preterm Delivery. Obstet Gynecol
105: 285-289
[Abstract][Full Text]
Plevyak, M. P., Lambert-Messerlian, G. M., Farina, A., Groome, N. P., Canick, J. A., Silver, H. M.
(2003). Concentrations of Serum Total Activin A and Inhibin A in Preterm and Term Labor Patients: A Cross-Sectional Study. Reproductive Sciences
10: 231-236
[Abstract]
Andrews, W. W., Sibai, B. M., Thom, E. A., Dudley, D., Ernest, J. M., McNellis, D., Leveno, K. J., Wapner, R., Moawad, A., O'Sullivan, M. J., Caritis, S. N., Iams, J. D., Langer, O., Miodovnik, M., Dombrowski, M.
(2003). Randomized Clinical Trial of Metronidazole Plus Erythromycin to Prevent Spontaneous Preterm Delivery in Fetal Fibronectin-Positive Women. Obstet Gynecol
101: 847-855
[Abstract][Full Text]
Sakai, M., Sasaki, Y., Yamagishi, N., Tanebe, K., Yoneda, S., Saito, S.
(2003). The Preterm Labor Index and Fetal Fibronectin for Prediction of Preterm Delivery With Intact Membranes. Obstet Gynecol
101: 123-128
[Abstract][Full Text]
Honest, H., Bachmann, L. M, Gupta, J. K, Kleijnen, J., Khan, K. S
(2002). Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ
325: 301-301
[Abstract][Full Text]
McKenna, D. S., Costa, S., Iams, J. D., Samuels, P.
(2002). Cervicovaginal Fetal Fibronectin Levels in Women With Preeclampsia. Obstet Gynecol
100: 266-270
[Abstract][Full Text]
Romero, R., Kuivaniemi, H., Tromp, G.
(2002). Functional Genomics and Proteomics in Term and Preterm Parturition. J. Clin. Endocrinol. Metab.
87: 2431-2434
[Full Text]
Ruiz, R. J., Fullerton, J., Brown, C. E. L., Schoolfield, J.
(2001). Relationships of Cortisol, Perceived Stress, Genitourinary Infections, and Fetal Fibronectin to Gestational Age at Birth. Biol Res Nurs
3: 39-48
[Abstract]
LU, G. C., GOLDENBERG, R. L., CLIVER, S. P., KREADEN, U. S., ANDREWS, W. W.
(2001). Vaginal Fetal Fibronectin Levels and Spontaneous Preterm Birth in Symptomatic Women. Obstet Gynecol
97: 225-228
[Abstract][Full Text]
Vause, S., Johnston, T.
(2000). Management of preterm labour. Arch. Dis. Child. Fetal Neonatal Ed.
83: 79F-85
[Full Text]
NICHOLSON, W. K., FRICK, K. D., POWE, N. R.
(2000). Economic Burden of Hospitalizations for Preterm Labor in the United States. Obstet Gynecol
96: 95-101
[Abstract][Full Text]
Ma, Y., Lockwood, C. J., Bunim, A. L., Giussani, D. A., Nathanielsz, P. W., Guller, S.
(2000). Cell Type-Specific Regulation of Fetal Fibronectin Expression in Amnion: Conservation of Glucocorticoid Responsiveness in Human and Nonhuman Primates. Biol. Reprod.
62: 1812-1817
[Abstract][Full Text]
Goldenberg, R. L., Hauth, J. C., Andrews, W. W.
(2000). Intrauterine Infection and Preterm Delivery. NEJM
342: 1500-1507
[Full Text]
Ryu, J. S., Majeska, R. J., Ma, Y., LaChapelle, L., Guller, S.
(1999). Steroid Regulation of Human Placental Integrins: Suppression of {alpha}2 Integrin Expression in Cytotrophoblasts by Glucocorticoids. Endocrinology
140: 3904-3908
[Abstract][Full Text]
Norwitz, E. R., Robinson, J. N., Challis, J. R.G.
(1999). The Control of Labor. NEJM
341: 660-666
[Full Text]
NUUTILA, M., HIILESMAA, V., KARKKAINEN, T., YLIKORKALA, O., RUTANEN, E.-M.
(1999). Phosphorylated Isoforms of Insulin-Like Growth Factor Binding Protein-1 in the Cervix as a Predictor of Cervical Ripeness. Obstet Gynecol
94: 243-249
[Abstract][Full Text]
MCKENNA, D. S., COSTA, S. W., SAMUELS, P.
(1999). Prostaglandin E2 Cervical Ripening Without Subsequent Induction of Labor. Obstet Gynecol
94: 11-14
[Abstract][Full Text]
CRANE, J. M. G., ANTHONY ARMSON, B., DODDS, L., FEINBERG, R. F., KENNEDY, W., KIRKLAND, S. A.
(1999). Risk Scoring, Fetal Fibronectin, and Bacterial Vaginosis to Predict Preterm Delivery. Obstet Gynecol
93: 517-522
[Abstract][Full Text]
McLaren, J., Malak, T.M., Bell, S.C.
(1999). Structural characteristics of term human fetal membranes prior to labour: identification of an area of altered morphology overlying the cervix. Hum Reprod
14: 237-241
[Abstract][Full Text]
Parry, S., Strauss, J. F.
(1998). Premature Rupture of the Fetal Membranes. NEJM
338: 663-670
[Full Text]
Yoon, D. Y., Ma, Y., Krikun, G., Lockwood, C. J., LaChapelle, L., Guller, S.
(1998). Glucocorticoid Effects in the Human Placenta: Evidence That Dexamethasone-Mediated Inhibition of Fibronectin Expression in Cytotrophoblasts Involves a Protein Intermediate. J. Clin. Endocrinol. Metab.
83: 632-637
[Abstract][Full Text]
Runic, R., Lockwood, C. J., LaChapelle, L., Dipasquale, B., Demopoulos, R. I., Kumar, A., Guller, S.
(1998). Apoptosis and Fas Expression in Human Fetal Membranes. J. Clin. Endocrinol. Metab.
83: 660-666
[Abstract][Full Text]
Jackson, G. M., Edwin, S. S., Varner, M. W., Casal, D., MItchell, M. D.
(1996). Regulation of Fetal Fibronectin Production in Human Amnion Cells. Reproductive Sciences
3: 85-88
[Abstract]
Mouw, R. J.C., Egberts, J., van Roosmalen, J. J.M., Kragt, H.
(1995). High Cervical Fetal-Fibronectin Concentrations and Birth within 3 Days in Pregnancies of 41 Weeks or More. NEJM
332: 1105-1105
[Full Text]
Radetsky, P
(1994). Stopping premature births before it's too late. Science
266: 1486-1488
Hay, P E, Lamont, R F, Taylor-Robinson, D, Morgan, D J, Ison, C, Pearson, J
(1994). Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ
308: 295-298
[Abstract][Full Text]
(1991). TEST MAY DISTINGUISH TRUE FROM FALSE PREMATURE LABOR. JWatch General
1991: 6-6
[Full Text]
